Adaptive Approach to Naltrexone Treatment for Alcoholism

Naltrexone (NTX) is an opioid receptor antagonist used to prevent alcoholism relapse. This trial examines how to define “non-response” to treatment with NTX and what treatments are most effective for those who do or do not respond to the initial treatment.

  • PI: David Oslin
  • Location: University of Pennsylvania
  • Funding: NIAAA Project R01AA017164